1CM (MILFF) ROC (Joel Greenblatt) %: 84.68% (As of Feb. 2026)


MILFF 1CM Inc MILFF
50 GF Score
Price $0.08
GF Value $0.27
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is 1CM ROC (Joel Greenblatt) %?

1CM MILFF 50 ROC (Joel Greenblatt) % is 84.68% as of Feb. 2026. GuruFocus rates MILFF with a GF Score™ of 50/100 and a GF Value™ of $0.27 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 977 Drug Manufacturers companies, 1CM ranks better than 77.28% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. 1CM's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 84.68%.

The historical rank and industry rank for 1CM's ROC (Joel Greenblatt) % or its related term are showing as below:

MILFF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -675.71   Med: -62.69   Max: 34.2
Current: 34.2

During the past 13 years, 1CM's highest ROC (Joel Greenblatt) % was 34.20%. The lowest was -675.71%. And the median was -62.69%.

MILFF's ROC (Joel Greenblatt) % is ranked better than
77.28% of 977 companies
in the Drug Manufacturers industry
Industry Median: 11.37 vs MILFF: 34.20

1CM's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


1CM  (OTCPK:MILFF) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


1CM ROC (Joel Greenblatt) % Related Terms


1CM ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for 1CM's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

1CM ROC (Joel Greenblatt) % Chart

1CM Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -95.24 -77.21 8.76 15.45 9.61

1CM Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.60 7.91 10.08 13.64 84.68

MILFF vs ZTS, UTHR: ROC (Joel Greenblatt) % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, 1CM's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


1CM ROC (Joel Greenblatt) % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 1CM's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where 1CM's ROC (Joel Greenblatt) % falls into.


MILFF
50GF Score
1CM Inc MILFF
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

1CM ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Nov. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.793 + 0.967 + 19.034) - (2.896 + 0 + 3.681)
=14.217

Working Capital(Q: Feb. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.925 + 0.87 + 18.167) - (3.598 + 0 + 2.736)
=13.628

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of 1CM for the quarter that ended in Feb. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Feb. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2025  Q: Feb. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=13.448/( ( (1.873 + max(14.217, 0)) + (2.044 + max(13.628, 0)) )/ 2 )
=13.448/( ( 16.09 + 15.672 )/ 2 )
=13.448/15.881
=84.68 %

Note: The EBIT data used here is four times the quarterly (Feb. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 84.68% mean?
1CM (MILFF) has a ROC (Joel Greenblatt) % of 84.68% as of Feb. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on 1CM and its competitors. According to the industry distribution chart, 1CM ranks #222 out of 977 companies in the Drug Manufacturers industry, placing it in the top 22.7%.
Is 1CM's ROC (Joel Greenblatt) % too high?
1CM's current ROC (Joel Greenblatt) % is 84.68%. The Drug Manufacturers industry median ROC (Joel Greenblatt) % is 11.37. 1CM's value of 84.68% is 644.8% above this industry median. Based on the distribution chart, 1CM ranks #222 out of 977 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, 1CM has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 1CM's ROC (Joel Greenblatt) % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, 1CM ranks #222 out of 977 companies for ROC (Joel Greenblatt) %. This places 1CM in the top 23% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 11.37. 1CM's value of 84.68% is 644.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.37, based on 977 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 1CM's current ROC (Joel Greenblatt) % of 84.68% is 644.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on 1CM and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 1CM's current ROC (Joel Greenblatt) % is 84.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 1CM stock overvalued right now?
Based on GuruFocus' analysis, 1CM (MILFF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.27, compared to a current price of $0.08 — trading 71.1% below its estimated fair value. The current ROC (Joel Greenblatt) % is 84.68% and 644.8% above the Drug Manufacturers industry median of 11.37. 1CM's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For 1CM (MILFF), the current ROC (Joel Greenblatt) % is 84.68% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 1CM (MILFF) Overvalued in 2026?

Based on GuruFocus' analysis, 1CM stock appears to be undervalued. The current stock price of $0.08 is trading 71.1% below its estimated GF Value™ of $0.27. GuruFocus considers 1CM to be Significantly Undervalued.

Key valuation signals for MILFF:

  • ROC (Joel Greenblatt) %: 84.68%
  • GF Value™: $0.27 vs. price of $0.08 (71.1% below fair value)
  • GF Score™: 50/100 with 3 warning signs
  • Industry Position: 644.8% above the Drug Manufacturers median (#222 of 977)

No single metric tells the full story. See the MILFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


1CM Business Description

Other Exchanges EPIC:Canada
Address 625 Cochrane Drive, Suite 802, Markham, ON, CAN, L3R9R9
1CM Inc is a multi-jurisdictional cannabis company focused on its retail customers and technology to democratize cannabis markets. The Company focuses on expanding its current operations through organic growth and by way of merger and acquisition transactions. It has a single operating segment, being Cannabis.
50GF Score

Get the complete analysis for MILFF

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.27
GF Value